Human neutrophil antigen-3 allele mismatching among kidney transplant patients with rejection

Authors

  • Pyae Mon Kyaw Medical Technology Program, Faculty of Associated Medical Sciences, Khon Kaen University
  • Chitranon Chan-on Internal Medicine Department, Faculty of Medicine, Khon Kaen University
  • Chanvit Leelayuwat Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University
  • Amornrat Romphruk Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University
  • Piyapong Simtong Centre for Research and Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen University

Keywords:

Graft rejection, Antibody mediated rejection, Kidney transplantation, Human neutrophil antigen

Abstract

Abstract:

Introduction: To date, the study of HNA-3 genotype mismatching in kidney-transplant patients with antibody-mediated rejection (AMR) has not been reported. Objective: To determine the extent of HNA-3 genotype mismatching and to estimate the risk of HNA-3 alloimmunization and also detect anti-HNA-3 antibodies among kidney-transplant patients with AMR. Materials and Methods: Ninety pairs of recipients and the corresponding donors were genotyped for the HNA-3 system and an HNA-3a variant (C451T) by polymerase chain reaction using sequence-specific primers (PCR-SSP). HNA-3 antibodies were investigated using the granulocyte agglutination test (GAT) and the LabScreen Multi HNA kit. Results: Patients with AMR had frequencies of HNA-3a/3a, HNA-3a/3b and HNA-3b/3b of 0.567, 0.355 and 0.078, respectively, while the frequencies in the corresponding donors were 0.556, 0.433 and 0.011, respectively. The risk of alloimmunization for HNA-3a was 0.072. HNA-3a incompatibility was found in 21% and HNA-3b in 79%. No AMR patients exhibited HNA-3a and HNA-3b antibodies. However, patients with AMR due to HLA-class I and/or class II antibodies were found. Conclusion: Our data provide evidence that the chance of HNA-3 incompatibility in kidney-transplant recipients is high (36.7% in this study) despite which, HNA-3a antibodies were not detected. Taken together, these findings indicate that HNA-3a antibodies are less important for the pathomechanism of kidney transplant rejection.

Downloads

Download data is not yet available.

References

1. Greinacher A, Wesche J, Hammer E, Fürll B, Völker U, Reil A, et al. Characterization of the human neutrophil alloantigen-3a. Nat Med. 2010;16:45-8.
2. Nair TS, Kozma KE, Hoefling NL, Kommareddi PK, Ueda Y, Gong TW, et al. Identification and characterization of choline transporter-like protein 2, an inner ear glycoprotein of 68 and 72 kDa that is the target of antibody-induced hearing loss. J Neurosci. 2004;24:1772-9.
3. Kommareddi PK, Nair TS, Thang LV, Galano MM, Babu E, Ganapathy V, et al. Isoforms, expression, glycosylation, and tissue distribution of CTL2/SLC44A2. Protein J. 2010;29:417-26.
4. Flesch BK, Reil A. Molecular genetics of the human neutrophil antigens. Transfus Med Hemother. 2018;45:300-9.
5. Flesch BK, Reil A, Bux J. Genetic variation of the HNA-3a encoding gene. Transfusion. 2011;51:2391-7.
6. Bayat B, Tjahjono Y, Sydykov A, Werth S, Hippenstiel S, Weissmann N, et al. Anti-human neutrophil antigen-3a induced transfusion-related acute lung injury in mice by direct disturbance of lung endothelial cells. Arterioscler Thromb Vasc Biol. 2013;33:2538-48.
7. Davoren A, Curtis BR, Shulman IA, Mohrbacher AF, Bux J, Kwiatkowska BJ, et al. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion. 2003;43:641-5.
8. Xia W, Simtong P, Santoso S. Neutrophil alloantigens and alloantibodies in different populations. ISBT Sci Ser. 2017;12:62-7.
9. Germain M, Chasman DI, de Haan H, Tang W, Lindström S, Weng LC, et al.
Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism. Am J Hum Genet. 2015;96:532-42.
10. Chen Q, Srivastava K, Liu Z, Xiao J, Huang C, Sun J, et al. Genotype frequency of human neutrophil antigen-3 polymorphisms in the Yi, Han, and Tibetan populations of China. Transfusion. 2016;56:737-42.
11. Simtong P, Puapairoj C, Leelayuwat C, Santoso S, Romphruk AV. Assessment of HNA alloimmunisation risk in Northeastern Thais, Burmese and Karen. Transfus Med. 2018;28:47-55.
12. Reil A, Wesche J, Greinacher A, Bux J. Geno- and phenotyping and immunogenicity of HNA-3. Transfusion. 2011;51:18-24.
13. Ou GJ, Su PC, Yu H, Ji X, Liu F, Wang SL, et al. HNA-3a and HNA-3b antigens among 9 ethnic populations and the Han population in Southwest China. J Transl Med. 2018;16:67.
14. Montoliu J, Cheigh JS, Mouradian JA, Suthanthiran M, Riggio RR, Rubin AL, et al. Delayed hyperacute rejection in recipients of kidney transplants from HLA identical sibling donors. Am J Med. 1979;67:590-6.
15. Grafft CA, Cornell LD, Gloor JM, Cosio FG, Gandhi MJ, Dean PG, et al. Antibody-mediated rejection following transplantation from an HLA-identical sibling. Nephrol Dial Transplant. 2010;25:307-10.
16. Piotti G, Palmisano A, Maggiore U, Buzio C. Vascular endothelium as a target of immune response in renal transplant rejection. Front Immunol. 2014;5:505.
17. Key T, Carter V, Day S, Goodwin J, Goodwin P, Knight A, et al. Human Neutrophil Antibodies Associated with Early and Chronic Antibody Mediated Rejection in Kidney Transplant Recipients. J Renal Transplant Sci. 2018;2:81-84.
18. Haas M, Loupy A, Lefaucheur C, Roufosse C, Glotz D, Seron D, et al. The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am J Transplant. 2018;18:293-307.
19. Nathalang O, Intharanut K, Siriphanthong K, Nathalang S, Leetrakool N. Risk estimation of HNA-3 incompatibility and alloimmunization in Thai populations. PLoS One. 2015;10:e0116905. doi: 10.1371/journal.pone.0116905. PubMed PMID: 25608003; PubMed Central PMCID: PMC4301801.
20. Bux J, Chapman J. Report on the second international granulocyte serology workshop. Transfusion. 1997;37:977-83.
21. Lopes LB, Abbas SA, Moritz E, Martins JO, Chiba AK, Langhi DM Jr, et al. Antibodies to human neutrophil antigen HNA-3b implicated in cases of neonatal alloimmune neutropenia. Transfusion. 2018;58:1264-70.
22. Bierling P, Bux J, Curtis B, Flesch B, Fung L, Lucas G, et al. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury. Vox Sang. 2009;96:266-9.
23. Bougie DW, Peterson JA, Kanack AJ, Curtis BR, Aster RH. Transfusion-related acute lung injury-associated HNA-3a antibodies recognize complex determinants on choline transporter-like protein 2. Transfusion. 2014;54:3208-15.

Downloads

Published

2021-09-09

Issue

Vol. 31 No. 3: July-September 2021

Section

นิพนธ์ต้นฉบับ (Original article)